Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Tectonic Therapeutic Inc (NASDAQ: TECX) closed at $17.65 up 1.79% from its previous closing price of $17.34. In other words, the price has increased by $1.79 from its previous closing price. On the day, 0.65 million shares were traded. TECX stock price reached its highest trading level at $18.77 during the session, while it also had its lowest trading level at $17.21.
Ratios:
For a deeper understanding of Tectonic Therapeutic Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 25.60 and its Current Ratio is at 25.60. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Oppenheimer on September 03, 2025, initiated with a Outperform rating and assigned the stock a target price of $80.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 11 ’25 when SPRINGER TIMOTHY A bought 53,706 shares for $16.31 per share. The transaction valued at 875,945 led to the insider holds 1,503,358 shares of the business.
SPRINGER TIMOTHY A bought 45,858 shares of TECX for $767,204 on Apr 10 ’25. The Director now owns 1,449,652 shares after completing the transaction at $16.73 per share. On Apr 09 ’25, another insider, SPRINGER TIMOTHY A, who serves as the Director of the company, bought 21,071 shares for $14.76 each. As a result, the insider paid 311,020 and bolstered with 1,403,794 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TECX now has a Market Capitalization of 330269056 and an Enterprise Value of 44831060.
Stock Price History:
The Beta on a monthly basis for TECX is 1.42, which has changed by -0.5173949 over the last 52 weeks, in comparison to a change of 0.13033986 over the same period for the S&P500. Over the past 52 weeks, TECX has reached a high of $61.07, while it has fallen to a 52-week low of $13.70. The 50-Day Moving Average of the stock is -6.27%, while the 200-Day Moving Average is calculated to be -26.73%.
Shares Statistics:
For the past three months, TECX has traded an average of 404.04K shares per day and 503210 over the past ten days. A total of 18.71M shares are outstanding, with a floating share count of 10.58M. Insiders hold about 43.45% of the company’s shares, while institutions hold 61.20% stake in the company. Shares short for TECX as of 1759190400 were 2849373 with a Short Ratio of 7.05, compared to 1756425600 on 2586743. Therefore, it implies a Short% of Shares Outstanding of 2849373 and a Short% of Float of 26.8.
Earnings Estimates
At present, 7.0 analysts are actively evaluating the performance of Tectonic Therapeutic Inc (TECX) in the stock market.The consensus estimate for the next quarter is -$1.07, with high estimates of -$0.84 and low estimates of -$1.35.
Analysts are recommending an EPS of between -$3.74 and -$4.45 for the fiscal current year, implying an average EPS of -$4.17. EPS for the following year is -$4.77, with 9.0 analysts recommending between -$3.81 and -$5.47.
